OncoCyte Corporation / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €1.62M +25.1% -€52.26M +118.4% -3,225.0% -14 pp -€17.40M -12.4% -1,073.7% +4.6 pp
    €1.29M +56.9% -€23.93M -62.2% -1,848.4% +58 pp -€19.85M -44.1% -1,533.2% +28 pp
    €825.36K -87.6% -€63.27M +14.6% -7,666.0% -68 pp -€35.52M +22.4% -4,303.5% -39 pp
    €6.66M +535.4% -€55.22M +114.1% -829.5% +16 pp -€29.03M +36.1% -436.1% +16 pp
    €1.05M +∞% -€25.79M +34.0% -2,461.5% -25 pp -€21.33M +31.7% -2,035.6% -20 pp
    €0.00 +NaN% -€19.24M +41.7% N/A -€16.19M +61.8% N/A
    €0.00 +NaN% -€13.57M -18.7% N/A -€10.01M -12.6% N/A
    €0.00 +NaN% -€16.69M +73.5% N/A -€11.45M +79.3% N/A
    €0.00 +NaN% -€9.62M +27.9% N/A -€6.39M +98.9% N/A
    €0.00 +NaN% -€7.53M +75.2% N/A -€3.21M +222.9% N/A
    €0.00 +NaN% -€4.30M +42.7% N/A -€995.09K +68.6% N/A
    €0.00 -€3.01M N/A -€590.16K N/A

    Notifications